| Company Name: | Accuray, Incorporated | | Ticker Symbol: | ARAY | | | WWW Address: | www.accuray.com | | CEO: | Dr. Euan S. Thomson, Ph.D. | | No. of Employees: | 458 | | Common Issue Type: | CS | | Business Description: | The Company designs, develops and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors anywhere in the body.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 5.54 |  0.13 | 5.0 | 6.0 | 5.41 | 5.61 | 5.37 | 183345 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 318.0 | 57.4 | 1.37 | 0.01 | 0.00 | 0.0 | 0.0 | 8.35 - 3.78 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 5.54 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 318.0 | mil |
| Latest Shares Outstanding | 57.4 | mil |
| Earnings pS (EPS) | 0.01 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 510,039 | $ |
| Effective Tax Rate | 8.3 | % |
| Float | 42.2 | mil |
| Float as % of Shares Outstanding | 74.4 | % |
| Foreign Sales | 62 | mil |
| Domestic Sales | 172 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 33.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 15.30 | % |
| Gross Profit Margin | 50.4 | % |
| EBITDA Margin | 2.0 | % |
| Pre-Tax Profit Margin | 0.3 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | 0.2 | % |
| Return on Equity (ROE) | 0.3 | % |
| Return on Capital Invested (ROCI) | 0.3 | % |
| Current Ratio | 1.9 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.56 | $ |
| Cash pS | 0.58 | $ |
| Book-Value pS | 2.70 | $ |
| Tangible Book-Value pS | 2.61 | $ |
| Cash Flow pS | 0.13 | $ |
| Free Cash Flow pS | -0.32 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.05 | |
| Price/Tangible Book Ratio | 2.12 | |
| Price/Cash Flow | 43.2 | |
| Price/Free Cash Flow | -17.4 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 100 | 1,745 | 7,274 |
| 4 Weeks | 6.15 | 5.28 | 6.00 | -7.7 | 91 | 2,199 | 43,971 |
| 13 Weeks | 7.58 | 5.28 | 7.40 | -25.1 | 70 | 2,522 | 161,417 |
| 26 Weeks | 8.35 | 5.28 | 5.94 | -6.7 | 76 | 2,835 | 360,076 |
| 52 Weeks | 8.35 | 3.78 | 4.32 | 28.2 | 94 | 3,204 | 804,292 |
| YTD | 8.35 | 3.78 | - | 7.4 | 89 | 3,165 | 712,216 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 5.60 | 5.59 | 6.20 | 6.44 | 6.10 | 1.37 | 1.37 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 71.57 | 91.2 | 34.84 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | -32.06 |
| R&D | 0.00 | NA | 21.23 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -10.3 | -10.3 | 11.0 |
| Earnings % | 0.0 | 0.0 | -88.7 |
| EPS % | 0.0 | 0.0 | -88.9 |
| EPS $ | 0.00 | 0.00 | -0.08 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 29.19 |
| Current Ratio | 1.7 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.91 |
| Receivables Turnover | 6.6 |
| Average Collection Period | 55 |
| Working Capital/Equity | 52.0 |
| Working Capital pS | 1.41 |
| Cash-Flow pS | 0.13 |
| Free Cash-Flow pS | -0.22 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.85 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 43.9 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 5.2 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 4.24 |
| Tobin's Q Ratio | 1.16 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 79.50 |
| Enterprise Value (EV)/Free Cash Flow | -36.62 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.12 |
| Price/Book Ratio - LTM | 2.05 |
| Price/Cash Flow Ratio | 43.2 |
| Price/Free Cash Flow Ratio - LTM | -17.4 |
| Price/Sales Ratio | 1.40 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.98 |
| Tangible Book Value pS - LTM | 2.61 |
| Book Value pS - LTM | 2.70 |
| Capital Invested pS | 2.68 |
| Cash pS - LTM | 0.58 |
| Cash Flow pS - LTM | 0.13 |
| Free Cash Flow pS - LTM | -0.32 |
| Earnings pS (EPS) | 0.01 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -5.26 |
| Free Cash Flow Margin 5YEAR AVG | 7.38 |
| Net Profit Margin | 0.3 |
| Net Profit Margin - 5YEAR AVRG. | -9.0 |
| Equity Productivity | 1.52 |
| Return on Equity (ROE) | 0.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.52 |
| Return on Capital Invested (ROCI) | 0.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -21.7 |
| Assets Productivity | 0.80 |
| Return on Assets (ROA) | 0.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | -5.3 |
| Gross Profit Margin | 50.4 |
| Gross Profit Margin - 5YEAR AVRG. | 55.4 |
| EBITDA Margin - LTM | 2.0 |
| EBIT Margin - LTM | 0.3 |
| Pre-Tax Profit Margin | 0.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -8.6 |
| Effective Tax Rate | 8.3 |
| Effective Tax Rate - 5YEAR AVRG. | -1.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 140 |
| Revenue per Employee | 510,039 |
| Net Income per Employee | 1,330 |
| Average Collection Period | 56 |
| Receivables Turnover | 6.6 |
| Day's Inventory Turnover Ratio | 84 |
| Inventory Turnover | 4.3 |
| Inventory/Sales | 12.4 |
| Accounts Payble/Sales | 6.40 |
| Assets/Revenue | 1.25 |
| Net Working Capital Turnover | 2.92 |
| Fixed Assets Turnover | 2.85 |
| Total Assets Turnover | 0.8 |
| Revenue per $ Cash | 6.34 |
| Revenue per $ Plant | 15.50 |
| Revenue per $ Common Equity | 1.52 |
| Revenue per $ Capital Invested | 1.52 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 35.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 43.1 |
| Research & Devlopment (R&D) as % of Revenue | 15.4 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 15.4 |
|
|  
|
| |
 |  |